- Home
- TROO vs ALEC Comparison
TROO vs ALEC Comparison
Compare TROO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- ALEC
- Stock Information
- Founded
- TROO 2005
- ALEC 2013
- Country
- TROO Hong Kong
- ALEC United States
- Employees
- TROO N/A
- ALEC N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TROO Technology
- ALEC Health Care
- Exchange
- TROO Nasdaq
- ALEC Nasdaq
- Market Cap
- TROO 103.8M
- ALEC 124.0M
- IPO Year
- TROO N/A
- ALEC 2019
- Fundamental
- Price
- TROO $1.04
- ALEC $2.76
- Analyst Decision
- TROO
- ALEC Buy
- Analyst Count
- TROO 0
- ALEC 8
- Target Price
- TROO N/A
- ALEC $4.50
- AVG Volume (30 Days)
- TROO 214.3K
- ALEC 1.4M
- Earning Date
- TROO 09-03-2025
- ALEC 11-05-2025
- Dividend Yield
- TROO N/A
- ALEC N/A
- EPS Growth
- TROO N/A
- ALEC N/A
- EPS
- TROO N/A
- ALEC N/A
- Revenue
- TROO $10,073,000.00
- ALEC $81,130,000.00
- Revenue This Year
- TROO N/A
- ALEC N/A
- Revenue Next Year
- TROO N/A
- ALEC $196.86
- P/E Ratio
- TROO N/A
- ALEC N/A
- Revenue Growth
- TROO 182.24
- ALEC 46.77
- 52 Week Low
- TROO $0.49
- ALEC $0.87
- 52 Week High
- TROO $4.64
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- TROO 58.49
- ALEC 63.74
- Support Level
- TROO $0.92
- ALEC $2.30
- Resistance Level
- TROO $1.09
- ALEC $3.07
- Average True Range (ATR)
- TROO 0.10
- ALEC 0.21
- MACD
- TROO -0.00
- ALEC 0.04
- Stochastic Oscillator
- TROO 62.82
- ALEC 70.11
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.